Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05014789 · ClinicalTrials.gov registry record · NA
Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study
A NA study, sponsored by Tandem Diabetes Care.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT05014789 is a NA study that has completed, run by Tandem Diabetes Care. The registered enrollment target is 66 participants.
The verdict
NCT05014789, a NA study, has completed, sponsored by Tandem Diabetes Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain preliminary safety and performance data on planned improvements to Control-IQ technology.
Interventions
- DEVICE Control-IQ technology 2.0
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2021-08-19 |
| Est. Completion | 2021-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05014789
The ClinicalTrials.gov registry entry for NCT05014789 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tandem Diabetes Care, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Control-IQ technology 2.0 is the first listed.
NCT05014789 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05014789 about?
NCT05014789 is a clinical study titled "Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study". The purpose of this study is to obtain preliminary safety and performance data on planned improvements to Control-IQ technology.
What is the current status of trial NCT05014789?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2021-08-19. Estimated completion is 2021-12-20.
What interventions are being tested in trial NCT05014789?
The interventions under investigation include: Control-IQ technology 2.0 (DEVICE).
Who is sponsoring clinical trial NCT05014789?
This trial is sponsored by Tandem Diabetes Care, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.